Asset Details
Do you wish to reserve the book?
Multivariate Mendelian randomization provides no evidence for causal associations among both psoriasis and psoriatic arthritis, and skin cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Multivariate Mendelian randomization provides no evidence for causal associations among both psoriasis and psoriatic arthritis, and skin cancer
Do you wish to request the book?
Multivariate Mendelian randomization provides no evidence for causal associations among both psoriasis and psoriatic arthritis, and skin cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Multivariate Mendelian randomization provides no evidence for causal associations among both psoriasis and psoriatic arthritis, and skin cancer
2023
Overview
Some retrospective studies reported that psoriasis (PsO) and psoriatic arthritis (PsA) may have been associated with an elevated risk of skin cancer. The causal associations among them remain unclear.
To evaluate the causal association of among both PsO and PsA, and skin cancer.
We performed large-scale two-sample and Multivariate Mendelian randomization analyses to examine whether there is a causal relationship between PsO and PsA, and skin cancer, encompassing basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), and cutaneous melanoma (CM).
Genetically predicted PsO, per log-odds ratio increase, showed no significant association with the risk of BCC, cSCC, and CM. The odds ratios (with corresponding 95% confidence intervals) for BCC, cSCC, and CM were 1.00 (0.99,1.01) (P
= 0.990), 0.94(0.89, 1.00) (P
= 0.065), and 0.99 (0.98, 1.01) (P
= 0.239), respectively. PsA showed a significant association with a decreased risk of BCC, with odds ratios (with corresponding 95% confidence intervals) of 1.00 (1.00, 1.00) (P
= 0.214) and 1.00 (1.00, 1.00) (P
= 0.477), respectively. Univariate analysis of the FinnGen database demonstrated PsA did exhibit a significant association with the decrease risk of BCC, with an odds ratio of 0.94(0.90,0.99) (P
= 0.016). However, this association disappeared after other risk factors were adjusted.
Our findings suggest no causal association between PsO and PsA and the genetic risk of skin cancer. Further observational studies are required to elucidate the relationship among PsO, PsA, and skin cancer.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
Arthritis, Psoriatic - complications
/ Arthritis, Psoriatic - epidemiology
/ Arthritis, Psoriatic - genetics
/ Biobanks
/ Carcinoma, Squamous Cell - complications
/ Datasets
/ effect
/ Genomes
/ Humans
/ Melanoma
/ Melanoma, Cutaneous Malignant
/ Mendelian Randomization Analysis
/ multivariate Mendelian randomization (MVMR)
/ Skin Neoplasms - complications
